The ELISA test for human soluble CD30 quantifies human sCD30 in serum, plasma, cell culture supernatants, urine or other human body fluids. The dosage will recognize only natural Hu sCD and...
The ELISA test for human soluble CD30 quantifies human sCD30 in serum, plasma, cell culture supernatants, urine or other human body fluids. The dosage will recognize only natural and recombinant Hu sCD30. Principle of the L-ELISA solid phase sandwich human sCD30 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples or controls are then added to these wells and are linked to immobilized antibodies (capture). The sandwich is formed by binding the second antibody (detector) to the target on a different epitope from the capture antibody. An antibody conjugated with the enzyme binds the formed sandwich. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
CD30 (Ki-1, member of TNF receptor superfamily 8) is a Type I transmembrane glycoprotein in the TNF receptor superfamily. CD30 was originally identified as a cell surface antigen of Hodgkins and Reed-Sternberg cells using Ki-1 monoclonal antibodies. The ligand for CD30 is CD30L (CD153). The CD30-CD30L binding allows for the mediating of pleiotropic effects, including cell proliferation, activation, differentiation and apoptotic cell death. CD30 plays a key role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulation molecule in the negative thymic selection. In addition to its expression in Hodgkin and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin lymphomas (including Burkitt lymphomas), virus-infected T and B cells, and normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells producing type 2 cytokines and on CD4 +/CD8+thymocytes co-expressing CD45RO and IL4 receptors. The soluble form of CD30 (SCD30) serves as a marker reflecting the Th2 immune response. TRAF2 and TRAF5 can interact with this receptor and intervene in the transduction of the signal leading to activation of NF-kappaB. CD30 is a positive regulator of apoptosis and has been shown to limit the proliferative potential of self-reactive CD8 T cells and protect the body from autoimmunity. Two alternative-spinning transcription variants of this gene coding distinct isoforms have been reported. CD30 is expressed by mononuclear cells of Hodgkin's lymphoma, Reed-Sternberg's cells, and most large anaplastic lymphoma (ALCL). The CD30 is also expressed by embryonic carcinomas.
Sensitivity
Sensitivity of the dosage: 0.33 ng.
Measurement range
Dose range: 1.6-100 ng/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation intra-dose 9.2%, inter-dose 12.9%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15561807 |
| Specifications |
| Accession number | P28908 |
| Dose range | 1.6-100 ng/ml |
| Sensitivity of the dosage | 0.33 ng |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant, Urine |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 943 |
| Gene symbol(s) | CD30,D1S166E,Ki-1 |
| Coefficient of inter-dose variation | 12.9% |
| Coefficient of intra-dose variation | 9.2% |
| Contents of kits | 96-well pre-coated microplate, Antibodies detection, Sample thinner, Sample thinner, lyophilized, Standard curve strips, Wash buffer concentrate, Stop solution, 10x lysis stamp, 10x lysis stamp, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Antigens of lymphoid activation CD30, Ki-1 |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 25 μl; Serum, 25 μl; Surnatant, 25 μl; Urine, 25 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS240INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.